Isoliquiritigenin (ISL) inhibits ErbB3 signaling in prostate cancer cells

Jae In Jung, Eunkyung Chung, Mi Ra Seon, Hyun Kyung Shin, Eun Ji Kim, Soon Sung Lim, Won Yoon Chung, Kwang Kyun Park, Jung Han Yoon Park

Research output: Contribution to journalArticlepeer-review

50 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Isoliquiritigenin (ISL) inhibits ErbB3 signaling in prostate cancer cells'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemistry